Produktbild: Prostate Biopsy
- 12%

Prostate Biopsy Indications, Techniques, and Complications

Aus der Reihe Current Clinical Urology
12% sparen

144,99 € UVP 164,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.03.2008

Abbildungen

77 illus., schwarz-weiss Illustrationen

Herausgeber

J. Stephen Jones

Verlag

Humana Press

Seitenzahl

344

Maße (L/B/H)

20,9/13,2/2,3 cm

Gewicht

459 g

Auflage

2008

Sprache

Englisch

ISBN

978-1-58829-790-7

Beschreibung

Rezension

From the reviews:



"20 chapters in this book read as independent articles that delve into many of the most recent discoveries and controversies surrounding prostate cancer diagnosis. … It presents a good overview of different variations on the PSA blood test and describes the key elements of prostate biopsy. This is a valuable resource for scientists/clinicians who are dedicated to working in the area of prostate cancer diagnosis. … The chapters provide excellent discussions of their topics and the book is an excellent resource for readers … ." (Ethan J Halpern, Doody’s Review Service, August, 2008)

Portrait

Steven Jones, MD, is the Vice Chairman of hte Glickman Urological Institute at the Cleveland Clinic Foundation, one of the foremost departments of urology in the world.  He is an expert in many aspects of urological science and medicine and has assembled the greatest international team to address the questions surrounding prostate biopsy.

 

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.03.2008

Abbildungen

77 illus., schwarz-weiss Illustrationen

Herausgeber

J. Stephen Jones

Verlag

Humana Press

Seitenzahl

344

Maße (L/B/H)

20,9/13,2/2,3 cm

Gewicht

459 g

Auflage

2008

Sprache

Englisch

ISBN

978-1-58829-790-7

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Prostate Biopsy
  • 1) Defining the Problem 2) WHAT EVERY PATIENT SHOULD KNOW ABOUT PROSTATE CANCER BEFORE HE SUBMITS TO BIOPSY OF HIS PROSTATE Authors: Thomas A. Stamey, MD*, Rosalie Nolley, MD and Dorothea Torti, MD - Stanford University Medical Center – S287, 300 Pasteur Drive, Stanford CA 94305 – tstamey@stanford.edu and tinyn@stanford.edu 3) PSA AND PROSTATE CANCER SCREENING Authors: Stacy Loeb, MD – Department of Urology, Georgetown University, 3800 Reservoir Rd, 4th floor PHC bldg., Washington DC 20007 Misop Han, MD and William J. Catalona, MD* – Department of Urology, Feinberg School of Medicine, Northwestern University, 675 N. St. Clair Suite 20-15, Chicago IL 60611 – wcatalona@nmff.org, wcataona@nmff.org, and stacyloeb@gmail.com 4) THE ROLE OF COMPLEXED PSA (cPSA) IN PROSTATE CANCER SCREENING Authors: Matthew E. Nielsen, MD* and Alan W. Partin, MD, PhD* – Brady Urological Institute, John Hopkins University School of Medicine, Marburg 143, 600 N Wolfe Street, Baltimore MD 21287 – apartin@jhmi.edu and nielsen@jhmi.edu 5) NEWLY RECOGNIZED FORMS OF PSA AND EMERGING MOLECULAR MARKERS Authors: Eduardo I. Canto, MD and Kevin M. Slawin, MD* – Antilles Research Institute, San Juan, PR and Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine – 6560 Fannin Street Suite 2100, Houston TX 77030 – kslawin@bcm.tmc.edu and ecanto@bcm.tmc.edu 6) THE ROLE OF PSA VELOCITY IN THE DIAGNOSIS AND MANAGEMENT OF PROSTATE CANCER Author: H. Ballentine Carter, MD* – James Buchanan Brady Urological Institute, John Hopkins School of Medicine, 600 N. Wolfe St., Baltimore MD 21287 – hcarter@jhmi.edu 7) PROSTATE CANCER SCREENING: NAVIGATING THE CONTROVERSY Authors: Timothy C. Brand, MD* and Ian M. Thompson, MD –Department of Urology, University of Texas Health Science Center, Mail Code 7845, 7703 Floyd Curl Drive, San Antonio TX 78229 – thompsoni@uthscsa.edu, thompsoni@uthscsa.edu and brandt2@uthscsa.edu Chapter Titles/Authors 4/27/2007 Page 2 of 3 8) PROSTATE CANCER NOMOGRAMS AND HOW THEY MEASURE UP TO NEURAL NETWORKS Authors: Pierre I. Karakiewicz, MD – Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal Quebec, Canada - and Michael W. Kattan, PhD* – Department of Quantitative Health Sciences, Cleveland Clinic, 9500 Euclid Avenue Wb-4, Cleveland OH 44195 – kattanm@ccf.org and pierre.karakiewicz@montreal.ca 9) PREPARATION FOR PROSTATE BIOPSY Authors: Alan M. Nieder, MD and Mark S. Soloway, MD* – Department of Urology, University of Miami Miller School of Medicine, PO Box 016960 (M814), Miami FL 33101 – msoloway@med.miami.edu and anieder@med.miami.edu 10) PRINCIPLES OF PROSTATE ULTRASOUND Author: Martha K. Terris, MD – Medical College of Georgia, 1120 15th Street BA-8414, Augusta GA 30912 – mterris@mcg.edu 11) MINIMIZING PAIN AND OPTIMIZING PATIENT EXPERIENCE DURING PROSTATE BIOPSY Author: J. Stephen Jones, MD, FACS* – Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue A100, Cleveland OH 44195 – joness7@ccf.org 12) PROSTATE BIOPSY TECHNIQUES Author: Katsuto Shinohara, MD* – Department of Urology and Mt. Zion, / Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero Street A634, San Francisco CA 94143 – kshinohara@urol.ucsf.edu 13) BIOPSY STRATEGIES – HOW MANY AND WHERE? Author: Joseph C. Presti, Jr., MD* – Stanford University School of Medicine, 875 Blake Wilbur Drive Rm 2217, Stanford Cancer